An Advanced Multivalent Ligand‐Decorated Microsphere Enrichment System Efficiently Captures Circulating Tumor Cells In Vivo
Small · 2025
DOI: 10.1002/smll.202409036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Xiao-Jie Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Microspheres, Cell Separation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Capturing circulating tumor cells (CTCs) in vivo from the bloodstream lessens tumor metastasis and recurrence risks. However, the absence of CTC receptors due to epithelial‐mesenchymal transition (EMT), the limited binding capacity of a single ligand, and the complexity of the blood flow environment significantly reduce the efficiency of CTC capture in vivo. Herein, a multivalent ligand‐decorated microsphere enrichment system (MLMES) is crafted that incorporates a capture column replete with an immunosorbent that precisely recognizes and binds the stably expressed cluster of differentiation 44 (CD44) and glucose transporter protein 1 (GLUT1) receptors present on the exterior of CTCs. As peripheral blood flows through the column, CTCs are efficiently captured, achieving an in vivo capture rate of up to 64.2%, the highest reported to date. Moreover, the MLMES demonstrates excellent biocompatibility, broad‐spectrum tumor cells capture, and storage stability. Importantly, it significantly eliminates a substantial quantity of CTCs from peripheral blood, reducing the risk of metastasis. This breakthrough method has broad clinical application potential in preventing tumor metastasis and recurrence, bringing new possibilities for improving cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China.
- Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing, 210009, China.
- College of Pharmacy, Yanbian University, Yanji, 133002, China.
- Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon, 16419, South Korea.
ORCID-Profile: Hu-Lin Jiang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- China Postdoctoral Science Foundation
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Fundamental Research Funds for the Central Universities
- State Key Laboratory of Natural Medicines China Pharmaceutical University
- Double First-class University Projects
- Double First Class University Plan
Zitieren
APA
Wang, X. J., Ji, Y. Z., Luo, J., Sun, Y., Zhou, T. J., Wang, Y., Xing, L., & Jiang, H. L. (2025). An Advanced Multivalent Ligand‐Decorated Microsphere Enrichment System Efficiently Captures Circulating Tumor Cells In Vivo. Small. https://doi.org/10.1002/smll.202409036
Vancouver
Wang XJ, Ji YZ, Luo J, Sun Y, Zhou TJ, Wang Y, et al. An Advanced Multivalent Ligand‐Decorated Microsphere Enrichment System Efficiently Captures Circulating Tumor Cells In Vivo. Small. 2025. doi:10.1002/smll.202409036
BibTeX
@article{Wang2025,
author = {Wang, Xiao-Jie and Ji, Yang-Ze and Luo, Jun and Sun, Ying and Zhou, Tian-Jiao and Wang, Yi and Xing, Lei and Jiang, Hu-Lin},
title = {An Advanced Multivalent Ligand‐Decorated Microsphere Enrichment System Efficiently Captures Circulating Tumor Cells In Vivo},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202409036}
}
EUVIMED